Inovio Pharmaceuticals, Inc. (INO)

Last Closing Price: 2.00 (2025-06-13)

Income after Taxes (Annual)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Inovio Pharmaceuticals, Inc. (INO) had Income after Taxes of $-107.25M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$0.22M
$-107.25M
--
$0.22M
$112.62M
$-112.40M
$5.14M
$-107.25M
$-107.25M
Income after Taxes
$-107.25M
$-107.25M
$-107.25M
$-107.25M
$-112.40M
$-109.27M
27.16M
27.16M
$-3.95
$-3.95
Balance Sheet Financials
$97.83M
$3.66M
$15.37M
$113.20M
$35.33M
--
$9.37M
$44.69M
$68.50M
$68.50M
$68.50M
36.10M
Cash Flow Statement Financials
$-104.08M
$104.07M
$51.48M
$14.31M
$65.81M
$51.50M
$6.60M
--
--
Fundamental Metrics & Ratios
2.77
--
--
--
--
100.00%
-51616.91%
-51616.91%
-50179.50%
-49254.27%
-49254.27%
$-104.51M
--
--
--
0.00
--
0.18
2009.84
-156.57%
-156.57%
-94.75%
-156.57%
$1.90
$-3.85
$-3.83